A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.
Share:
More In Business
From His Basement to ESPN: How Spikeball Became a Multimillion-Dollar Company
Chris Ruder, Spikeball Founder and CEO, explains how he and his friends put roundnet on the global map, plus, how Spikeball helps people "find their circle."
The Most Viral Game in College Football: The Pop-Tarts Bowl
Steve Hogan, CEO of Florida Citrus Sports, explains how he and his team made the Pop-Tarts Bowl one of the highest rated games in college football.
Disrupting The Music Industry: Venu Holding Corporation Rings NYSE Bell
J.W. Roth, CEO of Venu Holding Corporation, discusses the company's IPO and plans to redefine live music entertainment with their fan founded, fan-owned model.
Expert Predicts What Will Happen to TikTok in 75 Days
Andrew Graham, Head of Business Development for Digital Media at CAA, reacts to changes at TikTok and reveals his predictions for the app in 75 days.
Starbucks Plans Corporate Layoffs as Part of Turnaround
Starbucks says it plans an unspecified number of layoffs as it restructures its corporate staff.
Why Businesses in Hollywood Need to Come Back for the Working Class
Variety's Clayton Davis discusses why more than just the 1% are struggling after the LA fires. Plus, how awards shows will pivot to help victims. Watch!
Returns Recommerce: Rebelstork Saved More Than 12 Million Pounds of Product from Landfills in 2024
Emily Hosie, CEO of Rebelstork, explains the concept of Returns Recommerce, plus how her company raised $18M to address the industry-wide issue of returns.
Big Business This Week: The Most Expensive Natural Disaster in History
Economic damage could hit $250 billion. Plus, the SEC vs. Musk, Jeffrey Epstein's estate just got $111 million, and Jamie Dimon is forever.
Cybersecurity is Entering a New Era
Jim Guinn, EY Americas Cybersecurity Leader, shares how companies must stay vigilant and navigate the evolving regulatory landscape. *Sponsored by EY
